What is a Patient Advocate?
Drug Topics
APRIL 4, 2023
Health care advocates provide a vital service for patients who are managing chronic conditions.
Tue.Apr 04, 2023
467 
The silver linings in biotech’s wobbly market
PharmaVoice
APRIL 4, 2023
A report from accounting firm BDO compares biotech’s tough times with the booming last few years — and points to some silver linings.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Novel Agents Generate Excitement for Hematologic Malignancies
Drug Topics
APRIL 4, 2023
During a session at the 2023 HOPA Annual Conference, Rebecca Champion, PharmD, BCOP, highlighted new therapies in the market for hematologic malignancies with a focus on bispecific antibodies and chimeric antigen receptor T-cell therapies.
CMS coverage policy is detrimental to Alzheimer’s patients
PhRMA
APRIL 4, 2023
This week marks a somber anniversary for patients with Alzheimer’s. Last year, the Centers for Medicare & Medicaid Services (CMS) finalized a national coverage determination (NCD) that, for the first time ever, uses a coverage with evidence development (CED) policy that forces Medicare patients into highly restrictive research studies to simply gain access to new Alzheimer’s medicines that have been approved by the U.S.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
How HPV Self-Sampling Kits Save Money and Improve Screening Rates
Drug Topics
APRIL 4, 2023
In a recent trial, investigators found increased rates of screening when human papillomavirus (HPV) self-sampling kits were mailed to participants, and that this process costs less than usual care.
Arkansas puts patients first with new share the savings law
PhRMA
APRIL 4, 2023
Recently, Arkansas became the latest state to enact a law so that many patients aren’t paying more for their medicines than their insurance company or pharmacy benefit manager (PBM). The policy, commonly referred to as “share the savings,” requires insurers and the PBMs they work with to share the rebates, discounts, and other price concessions they receive from manufacturers directly with patients at the pharmacy counter.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: ‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J
STAT
APRIL 4, 2023
For the first time, Mark Cuban’s Cost Plus Drug Company is selling medicines made by a large drug manufacturer directly to consumers at a greatly reduced price, the latest sign that the billionaire is trying to make good on his vow to disrupt the opaque pharmaceutical supply chain. Until now, the company has focused on selling generic versions of brand-name medicines.
6 megadeals made up 40% of digital health funding in Q1 as smaller startups face rough waters: Rock Health
Fierce Healthcare
APRIL 4, 2023
6 megadeals made up 40% of digital health funding in Q1 as smaller startups face rough waters: Rock Health hlandi Tue, 04/04/2023 - 14:40
Connecting with Patients at Home
Pharmacy Is Right For Me
APRIL 4, 2023
There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! To learn about some of the more unique career settings in the industry, check out the Novel Pharmacy Practice Settings page —where you can explore these unique career pathways such as integrated health-community paramedicine.
From 'transformative' to 'tremendous fear': Takes on ChatGPT in healthcare at ViVE 2023
Fierce Healthcare
APRIL 4, 2023
From 'transformative' to 'tremendous fear': Takes on ChatGPT in healthcare at ViVE 2023 hlandi Tue, 04/04/2023 - 06:25
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Moderna exec: ‘There is nothing but global health’
PharmaVoice
APRIL 4, 2023
How Chantal Friebertshäuser is helping lead Moderna’s plan to expand its global reach.
J&J opens its wallet with whopping $8.9B talc settlement offer
Fierce Pharma
APRIL 4, 2023
J&J opens its wallet with whopping $8.
STAT+: The Q2 health tech tracker: 13 key industry events and milestones to watch
STAT
APRIL 4, 2023
Health tech companies are still plagued by a sluggish funding environment and a wobbling economy this quarter. Already this year, the industry has seen the demise of once-prominent mental health startup Mindstrong , and layoffs from the likes of Color and Cerebral. Still, startups have found opportunity in the world of AI medical scribes , buoyed by investor excitement in tools like ChatGPT.
Providers, payers press CMS to get rid of Medicare Advantage risk adjustment changes entirely
Fierce Healthcare
APRIL 4, 2023
Providers, payers press CMS to get rid of Medicare Advantage risk adjustment changes entirely rking Tue, 04/04/2023 - 15:08
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Ritual broadens retail distribution to Target
Drug Store News
APRIL 4, 2023
DSN spoke to Katerina Schneider, founder and CEO of the brand, about how the partnership with Target came to fruition, which was part of its plans to expand to mass retail.
Study finds half of cash prices below commercial rates in more than 2,000 hospitals
Fierce Healthcare
APRIL 4, 2023
Study finds half of cash prices below commercial rates in more than 2,000 hospitals rking Tue, 04/04/2023 - 16:32
Nair eases facial hair removal process with Prep & Smooth line
Drug Store News
APRIL 4, 2023
Nair Prep & Smooth Face is available in two fragrance variations—soothing coconut milk and collagen and hydrating watermelon extract and hyaluronic acid.
To build trust among LA’s unhoused, a street medicine team turns to technology
STAT
APRIL 4, 2023
LOS ANGELES — On an unusually cold and rainy Los Angeles afternoon, physician assistant Robert Finch is crouched in front of a man living in a pedestrian tunnel. It’s the first time they’ve met, after a local nonprofit asked Finch and his colleagues on a street medicine team to check in on the man’s mental and physical health.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
L’Oréal acquires A?sop
Drug Store News
APRIL 4, 2023
L’Oréal signed an agreement with Natura &Co. to acquire the luxury Australian beauty brand Aēsop.
Apple and Masimo face off in trial over patient monitoring patents
STAT
APRIL 4, 2023
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Improving Patient Outcomes: Collaborative Care in Primary Care Settings
Fierce Healthcare
APRIL 4, 2023
Improving Patient Outcomes: Collaborative Care in Primary Care Settings mteefey Tue, 04/04/2023 - 14:43
Fewer trips to the dentist? NYU College of Dentistry wins 2023 STAT Madness with a gel to treat gum disease
STAT
APRIL 4, 2023
It started with mice molars and a hunch. The New York University College of Dentistry team that won 2023’s STAT Madness competition developed a gel that could eventually replace painful cleanings for gum disease. The gel blocks receptors for a metabolite called succinate, reducing bone loss and inflammation and also changing the makeup of the bacteria found in the mouth.
Vertex and CRISPR Therapeutics submit BLAs to FDA for exa-cel
Pharmaceutical Technology
APRIL 4, 2023
Vertex Pharmaceuticals and CRISPR Therapeutics have completed the rolling submission of biologics licence applications (BLAs) to the US Food and Drug Administration (FDA) for exagamglogene autotemcel (exa-cel) to treat sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). The applications include requests for priority review. If granted, these would shorten the time taken for application review to eight months.
When confronted with mysterious illness in college, ‘Chronically Catherine’ started writing
STAT
APRIL 4, 2023
“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis to new patterns of living, to wrestling with big questions about illness and health. As Catherine Ames described it, this was quite a scene. She was hospitalized (again), and so weak and full of pain that she could barely walk. It took three Navy men holding her up to complete her daily walk around the ward.
Kroger celebrates Earth Month
Drug Store News
APRIL 4, 2023
Until April 30, customers can round up their purchases to the nearest dollar amount at checkout to benefit WWF, with Kroger's Zero Hunger | Zero Waste Foundation matching customer donations up to $50,000.
Opinion: Millions of people take birth control to treat endometriosis — but it doesn’t work
STAT
APRIL 4, 2023
At 14, after nearly three years of haunting the local urgent care clinic because of my intense menstrual periods, a doctor wrote a script that would alter the course of my life. It was for the birth control pill.
Eyad Farah departs McKesson
Drug Store News
APRIL 4, 2023
Farah has joined Orsini Specialty Pharmacy as COO.
STAT+: From a public library whiteboard, a $350 million biotech venture fund
STAT
APRIL 4, 2023
A new biotech VC firm started by veterans of the industry began around a whiteboard in two public libraries in suburban Massachusetts. David Fallace, Richard Lim, and Lou Tartaglia began gathering at the Newton and Wellesley, Mass. libraries in 2021 — locations away from the prying eyes of the Boston biotech ecosystem that also happened to be open during the pandemic — where they could dissect what worked, and what didn’t, in venture capital.
Alzheimer’s disease not forgotten as FDA oversees record number of designations awarded
Pharmaceutical Technology
APRIL 4, 2023
The FDA has seen a record surge in review designations being awarded over the last two years for Alzheimer’s indications, with 12 review designations being awarded to drugs between 2020 and 2022. This coincided with the much-anticipated wave of monoclonal antibody drugs for Alzheimer’s disease (AD) such as Eisai/Biogen’s Leqembi (lecanemab-irmb) and Eli Lilly’s donanemab, which are predicted to provide significant improvement on previous AD therapies.
STAT+: Pharmalittle: A ‘King Kong’ of weight-loss drugs is looming; FTC orders Illumina to divest Grail
STAT
APRIL 4, 2023
Hello, everyone, and how are you today? We are doing just fine, thank you, since a cool breeze and sunny skies are enveloping the Pharmalot campus. Moreover, the official mascot is happily occupied since his favorite playmate is here for a week-long slumber party. Squirrels beware. This leaves us to focus on matters at hand, which start with brewing cups of stimulation — butter pecan, for those keeping track — and foraging for items of interest.
Could reducing agar concentration enhance microbial growth?
European Pharmaceutical Review
APRIL 4, 2023
The pour plate method is used for microbiological control of pharmaceutical products and enumeration of microorganisms with low microbiological limits. Separating the agar from the other components of commonly used media during sterilisation and reducing the agar concentration to 10g/L can enhance microbial growth, a study has shown. Technological advances have allowed the development of rapid analytical techniques such as PCR or enzyme-linked immunosorbent assay (ELISA).
Walmart reopens redesigned Chesapeake, Va., store after fatal mass shooting
Drug Store News
APRIL 4, 2023
The redesigned store includes a memorial space to remember and honor the victims of the November 2022 tragedy.
Janssen launches once-daily option for prostate cancer drug Erleada
Pharmaceutical Technology
APRIL 4, 2023
On April 3, Janssen Pharmaceutical Companies of Johnson & Johnson announced the availability of an additional 240mg strength tablet for its prostate cancer drug ERLEADA (apalutamide) in the United States. Erleada is an androgen receptor inhibitor (ARI) indicated for treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and patients with metastatic castration-sensitive prostate cancer (mCSPC).
Let's personalize your content